Unexpected DOG-1 immunoreactivity in sarcomatous carcinoma of the liver: a diagnostic pitfall

Pathology. 2014 Oct;46(6):572-4. doi: 10.1097/PAT.0000000000000154.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anoctamin-1
  • Antineoplastic Agents / administration & dosage
  • Autopsy
  • Bile Duct Neoplasms / pathology*
  • Carcinoma / diagnostic imaging
  • Carcinoma / drug therapy
  • Carcinoma / secondary*
  • Carcinoma, Hepatocellular / diagnostic imaging
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / secondary*
  • Chloride Channels / metabolism*
  • Diagnosis, Differential
  • Fatal Outcome
  • Gastrointestinal Neoplasms / diagnosis
  • Gastrointestinal Stromal Tumors / diagnosis
  • Humans
  • Imatinib Mesylate / administration & dosage
  • Liver / pathology
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary*
  • Male
  • Neoplasm Proteins / metabolism*
  • Sarcoma / diagnostic imaging
  • Sarcoma / drug therapy
  • Sarcoma / secondary*
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • ANO1 protein, human
  • Anoctamin-1
  • Antineoplastic Agents
  • Chloride Channels
  • Neoplasm Proteins
  • Imatinib Mesylate